These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 26625717)

  • 21. Control of cell penetration enhancer shielding and endosomal escape-kinetics crucial for efficient and biocompatible siRNA delivery.
    Malfanti A; Sami H; Balasso A; Marostica G; Arpac B; Mastrotto F; Mantovani G; Cola E; Anton M; Caliceti P; Ogris M; Salmaso S
    J Control Release; 2023 Nov; 363():101-113. PubMed ID: 37722420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficient and safe delivery of siRNA using anionic lipids: Formulation optimization studies.
    Kapoor M; Burgess DJ
    Int J Pharm; 2012 Aug; 432(1-2):80-90. PubMed ID: 22575754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced gene delivery efficiency of cationic liposomes coated with PEGylated hyaluronic acid for anti P-glycoprotein siRNA: a potential candidate for overcoming multi-drug resistance.
    Ran R; Liu Y; Gao H; Kuang Q; Zhang Q; Tang J; Huang K; Chen X; Zhang Z; He Q
    Int J Pharm; 2014 Dec; 477(1-2):590-600. PubMed ID: 25448564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antineoplastic effects of liposomal short interfering RNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma.
    Riva G; Lagreca I; Mattiolo A; Belletti D; Lignitto L; Barozzi P; Ruozi B; Vallerini D; Quadrelli C; Corradini G; Forghieri F; Marasca R; Narni F; Tosi G; Forni F; Vandelli MA; Amadori A; Chieco-Bianchi L; Potenza L; Calabrò ML; Luppi M
    Haematologica; 2015 Nov; 100(11):e467-70. PubMed ID: 26206802
    [No Abstract]   [Full Text] [Related]  

  • 25. Effective siRNA delivery to inflamed primary vascular endothelial cells by anti-E-selectin and anti-VCAM-1 PEGylated SAINT-based lipoplexes.
    Leus NG; Talman EG; Ramana P; Kowalski PS; Woudenberg-Vrenken TE; Ruiters MH; Molema G; Kamps JA
    Int J Pharm; 2014 Jan; 459(1-2):40-50. PubMed ID: 24239833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced transfection rates of small-interfering RNA using dioleylglutamide-based magnetic lipoplexes.
    Lee S; Shim G; Kim S; Kim YB; Kim CW; Byun Y; Oh YK
    Nucleic Acid Ther; 2011 Jun; 21(3):165-72. PubMed ID: 21749293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges.
    Gomes-da-Silva LC; Fonseca NA; Moura V; Pedroso de Lima MC; Simões S; Moreira JN
    Acc Chem Res; 2012 Jul; 45(7):1163-71. PubMed ID: 22568781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RGD-based active targeting of novel polycation liposomes bearing siRNA for cancer treatment.
    Yonenaga N; Kenjo E; Asai T; Tsuruta A; Shimizu K; Dewa T; Nango M; Oku N
    J Control Release; 2012 Jun; 160(2):177-81. PubMed ID: 22019557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design of a Novel PEGylated Liposomal Vector for Systemic Delivery of siRNA to Solid Tumors.
    Song F; Sakurai N; Okamoto A; Koide H; Oku N; Dewa T; Asai T
    Biol Pharm Bull; 2019; 42(6):996-1003. PubMed ID: 31155597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted lipoplexes for siRNA delivery.
    Cardoso A; Trabulo S; Moreira JN; Düzgüneş N; de Lima MC
    Methods Enzymol; 2009; 465():267-87. PubMed ID: 19913172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro and in vivo effects of polyethylene glycol (PEG)-modified lipid in DOTAP/cholesterol-mediated gene transfection.
    Gjetting T; Arildsen NS; Christensen CL; Poulsen TT; Roth JA; Handlos VN; Poulsen HS
    Int J Nanomedicine; 2010 Aug; 5():371-83. PubMed ID: 20957159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative silencing of EGFP reporter gene by self-assembled siRNA lipoplexes of LinOS and cholesterol.
    Metwally AA; Blagbrough IS; Mantell JM
    Mol Pharm; 2012 Nov; 9(11):3384-95. PubMed ID: 23057412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of anti-E6 pegylated lipoplexes for mucosal application in the context of cervical preneoplastic lesions.
    Lechanteur A; Furst T; Evrard B; Delvenne P; Hubert P; Piel G
    Int J Pharm; 2015 Apr; 483(1-2):268-77. PubMed ID: 25701628
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ultrasound assisted siRNA delivery using PEG-siPlex loaded microbubbles.
    Vandenbroucke RE; Lentacker I; Demeester J; De Smedt SC; Sanders NN
    J Control Release; 2008 Mar; 126(3):265-73. PubMed ID: 18237813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PEGylated galactosylated cationic liposomes for hepatocytic gene delivery.
    Naicker K; Ariatti M; Singh M
    Colloids Surf B Biointerfaces; 2014 Oct; 122():482-490. PubMed ID: 25096720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complexation of siRNA and pDNA with cationic liposomes: the important aspects in lipoplex preparation.
    Barichello JM; Ishida T; Kiwada H
    Methods Mol Biol; 2010; 605():461-72. PubMed ID: 20072901
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-PEG IgM production by siRNA encapsulated in a PEGylated lipid nanocarrier is dependent on the sequence of the siRNA.
    Tagami T; Uehara Y; Moriyoshi N; Ishida T; Kiwada H
    J Control Release; 2011 Apr; 151(2):149-54. PubMed ID: 21223988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Core-shell type lipid/rPAA-Chol polymer hybrid nanoparticles for in vivo siRNA delivery.
    Gao LY; Liu XY; Chen CJ; Wang JC; Feng Q; Yu MZ; Ma XF; Pei XW; Niu YJ; Qiu C; Pang WH; Zhang Q
    Biomaterials; 2014 Feb; 35(6):2066-78. PubMed ID: 24315577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of cationic lipids in cationic liposomes and disaccharides in the freeze-drying of siRNA lipoplexes on gene silencing in cells by reverse transfection.
    Hattori Y; Hu S; Onishi H
    J Liposome Res; 2020 Sep; 30(3):235-245. PubMed ID: 31185779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor regression in mice by delivery of Bcl-2 small interfering RNA with pegylated cationic liposomes.
    Sonoke S; Ueda T; Fujiwara K; Sato Y; Takagaki K; Hirabayashi K; Ohgi T; Yano J
    Cancer Res; 2008 Nov; 68(21):8843-51. PubMed ID: 18974128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.